Showing 1 - 10 of 1,709
Is the exchange rate or the money growth rate the better instrument of monetary policy? A common argument is that the exchange rate has a natural advantage because it is more transparent: it is easier for the public to monitor than the money growth rate. We formalize this argument in a simple...
Persistent link: https://www.econbiz.de/10012470034
Persistent link: https://www.econbiz.de/10001630802
Persistent link: https://www.econbiz.de/10001637144
Persistent link: https://www.econbiz.de/10001854129
Persistent link: https://www.econbiz.de/10003349075
Monetary policy instruments differ in tightness-how closely they are linked to inflation-and transparency-how easily they can be monitored. Tightness is always desirable in a monetary policy instrument; when is transparency? When a government cannot commit to follow a given policy. We apply this...
Persistent link: https://www.econbiz.de/10012770718
Is the exchange rate or the money growth rate the better instrument of monetary policy? A common argument is that the exchange rate has a natural advantage because it is more transparent: it is easier for the public to monitor than the money growth rate. We formalize this argument in a simple...
Persistent link: https://www.econbiz.de/10013238694
This note is intended to introduce economists to a simple SIR model of the progression of COVID-19 in the United States over the next 12-18 months. An SIR model is a Markov model of the spread of an epidemic in a population in which the total population is divided into categories of being...
Persistent link: https://www.econbiz.de/10012482048
We document four facts about the COVID-19 pandemic worldwide relevant for those studying the impact of non-pharmaceutical interventions (NPIs) on COVID-19 transmission. First: across all countries and U.S. states that we study, the growth rates of daily deaths from COVID-19 fell from a wide...
Persistent link: https://www.econbiz.de/10012481267
We assess the economic value of screening testing programs as a policy response to the ongoing COVID-19 pandemic. We find that the fiscal, macroeconomic, and health benefits of rapid SARS-CoV-2 screening testing programs far exceed their costs, with the ratio of economic benefits to costs...
Persistent link: https://www.econbiz.de/10012482250